CH Polynesie Française
Papeete, French Polynesia
NCT Number: NCT04417777
Bronchiectasis, defined by an increase in bronchial caliber and thickening of the bronchial wall, is associated with recurrent respiratory infections, chronic cough and bronchorrhea, and a frequent progression to chronic respiratory failure. Investigator distinguish focal bronchiectasis usually resulting from a localized cause and diffuse bronchiectasis which the possible causes are multiple (immune deficiencies, genetic diseases, auto immune pathologies, aspergillosis broncho -allergic lung, sequelae of pulmonary infections).The etiological assessment is negative in 26 to 53% of cases, defining the idiopathic bronchiectasis. However, the discovery of an underlying cause can change the patient's management (up to 37% of cases).
Despite the lack of epidemiological data in French Polynesia, Australian and New Zealand studies found a high prevalence of bronchiectasis in Polynesians. Few clinical studies published in the early 1980s suggested a ciliary origin.
Due to its geographic characteristics, the Polynesian population constitutes an interesting ethnic group. Indeed, there is a low genetic mixing and the prevalence of certain genetic diseases like the syndrome of Alport or some hereditary retinal dystrophies are high. This type of population is very suitable for discovering new genes in human pathology.
Investigator decided to conduct an observational study to find an underlying genetic cause of bronchiectasis in Polynesians by performing a whole exome sequencing. Investigator chose to study index cases defined by an upset of symptoms during the childhood, a family history of idiopathic bronchiectasis, and/or a consanguinity. Investigator also want to study healthy first degree relatives, in order to be able to better identify the clinical significant of DNA variants and focus the analysis on those that may be pathogenic
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Papeete, French Polynesia
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
*Patients
Inclusion criteria
Exclusion criteria
*Relatives
Exclusion criteria
Blood analysis
Time frame: Anytime in the period of 10 years
New mutation in the coding region or mutation located outside the coding regions on the transcriptome
Time frame: Anytime in the period of 10 years
Extra-respiratory history Bronchial colonizations Scannographic aspect
Time frame: Anytime in the period of 10 years
Extra-respiratory history Bronchial colonizations Scannographic aspect
Time frame: Anytime in the period of 10 years
correlation genotype/phenotype
Time frame: Anytime in the period of 10 years
correlation genotype/phenotype
Centre Hospitalier Intercommunal Creteil
Other
Etude génétique Des Dilatations Des Bronches Idiopathiques en Polynésie française
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03750734
Bronchial Diseases, Bronchiectasis
Cambridge, United Kingdom
View Trial DetailsNCT07566611
Idiopathic Bronchiectasis
View Trial DetailsNCT01498263
Alzheimer Disease, Alzheimer's Disease and Related Dementias
Bethesda, Maryland, United States
View Trial DetailsNCT02156102
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Disease
Bethesda, Maryland, United States
View Trial Details